EcoR1 Capital, 10% Owner: Atara Biotherapeutics ATRA Buy · Filed 05/11

Trade details

Type: Insider buy
Amount: $4,744,255.45
Shares · price: 507,407 sh · $9.35 a share
Held after: 1,552,000 sh
Stock: Atara Biotherapeutics ATRA
Person: EcoR1 Capital10% Owner
Trade date: 26/05/07
Filed: 26/05/11
Days to filing: 4 days

First buy since 2023

Insiders buying this week: 1 insiders
Holding change: +48.6%

Atara Biotherapeutics trades, last 26 weeks

What else happened in Atara Biotherapeutics around then

Filed or reported within 30 days of the trade day · 04/07~06/06

EcoR1 Capital's recent trades

EcoR1 Capital10% Owner
SellFirst Tracks Biotherapeutics
Sell
First Tracks Biotherapeutics
TRAX
$65M
4,705,575 sh
$65M
Filed 04/22
Traded 04/20
EcoR1 CapitalDirector
BuyAktis Oncology
Buy
Aktis Oncology
AKTS
$37.4M
2,077,779 sh
$37.4M
Filed 01/12
Traded 01/12
EcoR1 CapitalDirector
BuyAktis Oncology
Buy
Aktis Oncology
AKTS
$2.6M
144,443 sh
$2.6M
Filed 01/12
Traded 01/12
EcoR1 Capital10% Owner
SellAdaptimmune Therapeutics
Sell
Adaptimmune Therapeutics
ADAPY
$3.7M
33,931,740 sh
$3.7M
Filed 25/07/30
Traded 25/07/28
EcoR1 Capital10% Owner
SellAdaptimmune Therapeutics
Sell
Adaptimmune Therapeutics
ADAPY
$2.7M
27,433,338 sh
$2.7M
Filed 25/07/30
Traded 25/07/30